SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Celgene-CELG
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
804 71 0 CELG
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
129 Hello again group, This stock appears to be spiralling down, and I'm not syolanda-12/15/1997
128 Stan: From medical dictionary: Anergy = absence of ability to generate a sensMiljenko Zuanic-12/8/1997
127 mz, There is an article in J of Exp Med 11.3.97 titled Prostaglandin E2 and TNFsquetch-12/8/1997
126 Peter: Initially I though about thalidomide as one which will bring attention Miljenko Zuanic-12/7/1997
125 Miljenko et al: Despite the caution expressed about thalidomide and HIV, it loBiomaven-12/6/1997
124 Max, Stan: Thanks for bringing to my and other attention the IL-12/INF-gama poMiljenko Zuanic-12/6/1997
123 Perhaps it is as mz says I can find one con, he can show one pro. If I were a ssquetch-12/6/1997
122 squetch, that seems to be the case *if* you accept their main conclusion. I haPseudo Biologist-12/5/1997
121 Hi MZ. I will review my file this weekend. For now, best I can say is that I John Bloxom-12/5/1997
120 PB thanks for checking it out. The JI abastract appears very bullish for use ofsquetch-12/5/1997
119 MZ, SQ, et al After reading the last 10 or so messages here I feel obligated tPseudo Biologist-12/5/1997
118 Hi John: >>ENMD reacquired these rights from BMY for substantial consideMiljenko Zuanic-12/5/1997
117 <<Any other reasons that BMY discontinue ENMD collaboration on thalidomidJohn Bloxom-12/5/1997
116 mz, The library I go to makes you get a card to do photocopies. I am not affilisquetch-12/5/1997
115 Stan: Can you send me Nature article. Otherwise will have to visit library. IMiljenko Zuanic-12/4/1997
114 Thanks Peter. It is not surprise that SBC, Prudential will follow, is initiatiMiljenko Zuanic-12/4/1997
113 mz and PB, Check the article in Nature 11.27.97 "Immunosuppressive effectssquetch-12/4/1997
112 In case you haven't seen this yet: Dillon-Read starts coverage with a &quoBiomaven-12/4/1997
111 Stan: >>I look forward to Max's interpretation.<< Yes, Max is Miljenko Zuanic-11/26/1997
110 Just found out the reason. secondary is going off at $9 biz.yahoo.comO-MY-O-11/26/1997
109 Just after 9am and 870k traded. No news I can find what's up? I got out atO-MY-O-11/26/1997
108 >>Did authors described the mechanism by which thalomide block IL-12 prodsquetch-11/26/1997
107 To All: Last week I had e-mail conversation with Stanley Quetchenbach regards Miljenko Zuanic-11/24/1997
106 Ed: Thanks for article. Good news for CELG. Peter: Agreed. CELG do not have Miljenko Zuanic-11/18/1997
105 On balance, the sale is good news. The business they sold was making a loss, anBiomaven-11/18/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News